Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Gary Korn who wrote (607)	11/5/1999 5:09:00 PM
From: Return to Sender	Read Replies (1) \| Respond to of 10345

Gary, do you use technical analysis much on stocks? ELAN reached a tremendously oversold condition this morning. The lower bollinger band was violated and the short term relative strength bounced off of a 20% rating. Obviously I could have bought shares for less today but in light of the statements made by Elan management those days should be numbered. It seems pretty obvious to me that analysts have been taking advantage of a rather minor delay in the delivery of that migraine drug. I mean lets be serious ELN stated that it would only amount to a 4 cent change in their own estimates. All they have to do is work a little harder to sell other products to make that up. In the meantime you can bet that the institutions were adding stock to their inventories at the very time that analysts have been downgrading this stock. ELN will move up from here. It might not move quickly because of the large float but unless you think ELN management is clueless about the future of their company's earnings then we should have seen the bottom today. Have a great weekend! Sender

To: Gary Korn who wrote (607)	11/5/1999 5:10:00 PM
From: All Mtn Ski	Read Replies (1) \| Respond to of 10345

Hopefully management's comments will help support the stock price, but are they really saying anything new? The Street ignored the positive year 2000 outlook in the 3Q results. Perhaps this is what the Street needs to wake up to the earnings story, I guess you have to take a bat to these people and beat the positives into them! <BG> It's good to know the management is aware of their stock price and shows concern for shareholders by bringing out the bat. Tom